JSS Medical Research Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Montreal QE Canada (1985)

Organization Overview

First Clinical Trial
2006
NCT00328263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CRO: JSS Medical Research India Pvt. Ltd. | JSS Medical Research Inc. | JSS Research

Active Ingredients

Drugs in Phase 3 Trials (5)

Key: JSS Medical Research Inc. (3) Acquired (2)

ferric derisomaltose (Monoferric) (2 trials)

ferric sulfate (1 trial)

gam-covid-vac lyo (1 trial)

Lactobacillus acidophilus (1 trial)

lactobacillus casei (1 trial)

Drugs in Phase 2 Trials (7)

eb05 (1 trial)

fe203799 (1 trial)

krill oil (1 trial)

nkpl66 (1 trial)

posaconazole (noxafil) (1 trial)

povidone-iodine (betadine) (1 trial)

trimebutine (1 trial)

Drugs in Phase 1 Trials (1)

glycovax-002 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Clostridium Infections (Phase 3)

Colonic Diseases (Phase 2)

Diarrhea (Phase 3)

Hodgkin Disease (Phase 2)

Hypertriglyceridemia (Phase 2)

Infections (Phase 3)

Lymphoma (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Mycoses (Phase 2)

Paronychia (Phase 2)

Pneumonia (Phase 2)

Visceral Pain (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 12
  • # of Trial APIs: 13